A Cholesterol-Based Allostery Model of T Cell Receptor Phosphorylation

Immunity

Volumn 44, Issue 5, 2016, Pages 1091-1101

  Swamy, Mahima ^a,b,c   Beck Garcia, Katharina ^a,b,d   Beck Garcia, Esmeralda ^a,b,e   Hartl, Frederike A ^a   Morath, Anna ^a,d   Yousefi, O Sascha ^a,d   Dopfer, Elaine Pashupati ^b   Molnár, Eszter ^a   Schulze, Anna K ^f,g   Blanco, Raquel ^h   Borroto, Aldo ^h   Martín Blanco, Nadia ^h   Alarcon, Balbino ^h   Höfer, Thomas ^f,g   Minguet, Susana ^a,b   Schamel, Wolfgang W A ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d UNIVERSITY OF FREIBURG   (Germany)

^e International Max Planck Research School for Molecular and Cellular Biology   (Germany)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; T LYMPHOCYTE RECEPTOR BETA CHAIN; ANTIGEN; HISTOCOMPATIBILITY ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE FRAGMENT; PROTEIN BINDING;

ALLOSTERISM; ARTICLE; CONTROLLED STUDY; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; ADAPTIVE IMMUNITY; BIOLOGICAL MODEL; HUMAN; IMMUNOLOGY; JURKAT CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; PHOSPHORYLATION; PROTEIN STABILITY; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; ALLOSTERIC REGULATION; ANTIGENS; CHOLESTEROL; HISTOCOMPATIBILITY ANTIGENS; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STABILITY; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84967142343     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2016.04.011     Document Type: Article

References (54)

1. Aivazian D., Stern L.J. Phosphorylation of T cell receptor zeta is regulated by a lipid dependent folding transition. Nat. Struct. Biol. 2000, 7:1023-1026.
2. Beck-Garcia E., Beck-Garcia K., Schlosser A., Schamel W.W. Analysis of interactions between proteins and fatty acids or cholesterol using a fatty acid/cholesterol pull-down-assay. Anal. Biochem. 2013, 436:75-77.
3. Blanco R., Borroto A., Schamel W., Pereira P., Alarcon B. Conformational changes in the T cell receptor differentially determine T cell subset development in mice. Sci. Signal. 2014, 7:ra115.
4. Boniface J.J., Rabinowitz J.D., Wülfing C., Hampl J., Reich Z., Altman J.D., Kantor R.M., Beeson C., McConnell H., Davis M.M. Initiation of signal transduction through the TCR requires the peptide multivalent engagement of MHC ligands. Immunity 1998, 9:459-466.
5. Borroto A., Arellano I., Dopfer E.P., Prouza M., Suchanek M., Fuentes M., Orfao A., Schamel W.W., Alarcon B. Nck Recruitment to the TCR Required for ZAP70 Activation during Thymic Development. J. Immunol. 2013, 190:1103-1112.
6. Brumeanu T.D., Preda-Pais A., Stoica C., Bona C., Casares S. Differential partitioning and trafficking of GM gangliosides and cholesterol-rich lipid rafts in thymic and splenic CD4 T cells. Mol. Immunol. 2007, 44:530-540.
7. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S., Thian F., Kobilka T., Choi H.J., Kuhn P., Weis W., Kobilka B.K., Stevens R.C. High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor. Science 2007, 318:1258-1265.
8. Choudhuri K., Wiseman D., Brown M.H., Gould K., van der Merwe P.A. TCR triggering is critically dependent on the dimensions of its peptide-MHC ligand. Nature 2005, 436:578-582.
9. Cochran J.R., Cameron T.O., Stern L.J. The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers. Immunity 2000, 12:241-250.
10. Contreras F.X., Ernst A., Haberkant P., Bjorkholm P., Lindahl E., Gonen B., Tischer C., Elofsson A., von Heijne G., Thiele C., et al. Molecular recognition of a single sphingolipid species by a protein's transmembrane domain. Nature 2012, 481:525-529.
11. Coskun U., Grzybek M., Drechsel D., Simons K. Regulation of human EGF receptor by lipids. Proc. Natl. Acad. Sci. USA 2011, 108:9044-9048.
12. Coskun U., Simons K. Cell membranes: the lipid perspective. Structure 2011, 19:1543-1548.
13. Davis M.M., Boniface J.J., Reich Z., Lyons D., Hampl J., Arden B., Chien Y. Ligand recognition by αβ T cell receptors. Annu. Rev. Immunol. 1998, 16:523-544.
14. Davis S.J., van der Merwe P.A. The kinetic-segregation model: TCR triggering and beyond. Nat. Immunol. 2006, 7:803-809.
15. de la Cruz J., Kruger T., Parks C.A., Silge R.L., van Oers N.S., Luescher I.F., Schrum A.G., Gil D. Basal and antigen-induced exposure of the proline-rich sequence in CD3ε. J. Immunol. 2011, 186:2282-2290.
16. Deswal S., Schulze A.K., Hofer T., Schamel W.W. Quantitative analysis of protein phosphorylations and interactions by multi-colour IP-FCM as an input for kinetic modelling of signalling networks. PLoS ONE 2011, 6:e22928.
17. Fahmy T.M., Bieler J.G., Edidin M., Schneck J.P. Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen. Immunity 2001, 14:135-143.
18. Falck E., Patra M., Karttunen M., Hyvonen M.T., Vattulainen I. Lessons of slicing membranes: interplay of packing, free area, and lateral diffusion in phospholipid/cholesterol bilayers. Biophys. J. 2004, 87:1076-1091.
19. Gil D., Schamel W.W., Montoya M., Sanchez-Madrid F., Alarcon B. Recruitment of Nck by CD3 epsilon reveals a ligand-induced conformational change essential for T cell receptor signaling and synapse formation. Cell 2002, 109:901-912.
20. Gimpl G., Gehrig-Burger K. Cholesterol reporter molecules. Biosci. Rep. 2007, 27:335-358.
21. Hanson M.A., Cherezov V., Griffith M.T., Roth C.B., Jaakola V., Chien E.Y., Velasquez J., Kuhn P., Stevens R.C. A specific cholesterol binding site is established by the 2.8 A structure of the human β2-adrenergic receptor. Structure 2008, 16:897-905.
22. Horejsi V. The roles of membrane microdomains (rafts) in T cell activation. Immunol. Rev. 2003, 191:148-164.
23. Iwashima M., Irving B.A., van Oers N.S., Chan A.C., Weiss A. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 1994, 263:1136-1139.
24. Kabouridis P.S., Janzen J., Magee A.L., Ley S.C. Cholesterol depletion disrupts lipid rafts and modulates the activity of multiple signaling pathways in T lymphocytes. Eur. J. Immunol. 2000, 30:954-963.
25. Kaech S.M., Hemby S., Kersh E., Ahmed R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 2002, 111:837-851.
26. Kim J.E., White F.M. Quantitative analysis of phosphotyrosine signaling networks triggered by CD3 and CD28 costimulation in Jurkat cells. J. Immunol. 2006, 176:2833-2843.
27. Kim S.T., Takeuchi K., Sun Z.Y., Touma M., Castro C.E., Fahmy A., Lang M., Wagner G., Reinherz E.L. The αβ T cell receptor is an anisotropic mechanosensor. J. Biol. Chem. 2009, 284:31028-31037.
28. Krogsgaard M., Li Q.J., Sumen C., Huppa J.B., Huse M., Davis M.M. Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity. Nature 2005, 434:238-243.
29. Kuhns M.S., Davis M.M. TCR signaling emerges from the sum of many parts. Front. Immunol. 2012, 3:159.
30. Kumar R., Ferez M., Swamy M., Arechaga I., Rejas M.T., Valpuesta J.M., Schamel W.W., Alarcon B., van Santen H.M. Increased Sensitivity of Antigen-Experienced T Cells through the Enrichment of Oligomeric T Cell Receptor Complexes. Immunity 2011, 35:375-387.
31. Lee M.S., Glassman C.R., Deshpande N., Badgandi H., Parrish H.L., Uttamapinant C., Stawski P.S., Ting A.Y., Kuhns M.S. A Mechanical Switch Couples T Cell Receptor Triggering to the Cytoplasmic Juxtamembrane Regions of CD3ζζ. Immunity 2015, 43:227-239.
32. Martinez-Martin N., Risueno R.M., Morreale A., Zaldivar I., Fernandez-Arenas E., Herranz F., Ortiz A.R., Alarcon B. Cooperativity between T cell receptor complexes revealed by conformational mutants of CD3ε. Sci. Signal. 2009, 2:ra43.
33. Mingueneau M., Sansoni A., Gregoire C., Roncagalli R., Aguado E., Weiss A., Malissen M., Malissen B. The proline-rich sequence of CD3ε controls TCR expression on and signaling potency in preselection CD4+CD8+ thymocytes. Nat. Immunol. 2008, 9:522-532.
34. Minguet S., Schamel W.W.A. A permissive geometry model for TCR-CD3 activation. Trends Biochem. Sci. 2008, 33:51-57.
35. Minguet S., Swamy M., Alarcon B., Luescher I.F., Schamel W.W. Full activation of the T cell receptor requires both clustering and conformational changes at CD3. Immunity 2007, 26:43-54.
36. Molnar E., Swamy M., Holzer M., Beck-Garcia K., Worch R., Thiele C., Guigas G., Boye K., Luescher I.F., Schwille P., et al. Cholesterol and sphingomyelin drive ligand-independent T-cell antigen receptor nanoclustering. J. Biol. Chem. 2012, 287:42664-42674.
37. Monod J., Wyman J., Changeux J.P. On the nature of allosteric transitions: a plausible model. J. Mol. Biol. 1965, 12:88-118.
38. Montixi C., Langlet C., Bernard A.M., Thimonier J., Dubois C., Wurbel M., Chauvin J., Pierres M., He H.T. Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains. EMBO J. 1998, 17:5334-5348.
39. Nika K., Soldani C., Salek M., Paster W., Gray A., Etzensperger R., Fugger L., Polzella P., Cerundolo V., Dushek O., et al. Constitutively active LCK kinase in T cells drives antigen receptor signal transduction. Immunity 2010, 32:766-777.
40. O'Shea J.J., McVicar D., Bailey T., Burns C., Smyth M.J. Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation. Proc. Natl. Acad. Sci. USA 1992, 89:10306-10310.
41. Petersen T.R., Gulland S., Bettelli E., Kuchroo V., Palmer E., Backstrom B.T. A chimeric T cell receptor with super-signaling properties. Int. Immunol. 2004, 16:889-894.
42. Potter T.A., Rajan T., Dick R.F., Bluestone J.A. Substitution at residue 227 of H-2 class I molecules abrogates recognition by CD8-dependent, but not CD8-independent, cytotoxic T lymphocytes. Nature 1989, 337:73-75.
43. Risueno R.M., Gil D., Fernandez E., Sanchez-Madrid F., Alarcon B. Ligand-induced conformational change in the T-cell receptor associated with productive immune synapses. Blood 2005, 106:601-608.
44. Risueno R.M., Schamel W.W., Alarcon B. T cell receptor engagement triggers its CD3ε and CD3ζ subunits to adopt a compact, locked conformation. PLoS ONE 2008, 3:e1747.
45. Rouquette-Jazdanian A.K., Pelassy C., Breittmayer J.P., Aussel C. Revaluation of the role of cholesterol in stabilizing rafts implicated in TCR signaling. Cell. Signal. 2006, 18:105-122.
46. Schamel W.W., Arechaga I., Risueno R.M., van Santen H.M., Cabezas P., Risco C., Valpuesta J.M., Alarcon B. Coexistence of multivalent and monovalent TCRs explains high sensitivity and wide range of response. J. Exp. Med. 2005, 202:493-503.
47. Shi X., Bi Y., Yang W., Guo X., Jiang Y., Wan C., Li L., Bai Y., Guo J., Wang Y., et al. Ca2+ regulates T-cell receptor activation by modulating the charge property of lipids. Nature 2013, 493:111-115.
48. Steinberg M., Adjali O., Swainson L., Merida P., Di Bartolo V., Pelletier L., Taylor N., Noraz N. T-cell receptor-induced phosphorylation of the ζ chain is efficiently promoted by ZAP-70 but not Syk. Blood 2004, 104:760-767.
49. Tani-ichi S., Maruyama K., Kondo N., Nagafuku M., Kabayama K., Inokuchi J., Shimada Y., Ohno-Iwashita Y., Yagita H., Kawano S., Kosugi A. Structure and function of lipid rafts in human activated T cells. Int. Immunol. 2005, 17:749-758.
50. Thiele C., Hannah M.J., Fahrenholz F., Huttner W.B. Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat. Cell Biol. 2000, 2:42-49.
51. van der Merwe P.A., Dushek O. Mechanisms for T cell receptor triggering. Nat. Rev. Immunol. 2011, 11:47-55.
52. Xavier R., Brennan T., Li Q., McCormack C., Seed B. Membrane compartmentation is required for efficient T cell activation. Immunity 1998, 8:723-732.
53. Xu C., Gagnon E., Call M.E., Schnell J.R., Schwieters C.D., Carman C.V., Chou J.J., Wucherpfennig K.W. Regulation of T cell receptor activation by dynamic membrane binding of the CD3ε cytoplasmic tyrosine-based motif. Cell 2008, 135:702-713.
54. Yang W., Bai Y., Xiong Y., Zhang J., Chen S., Zheng X., Meng X., Li L., Wang J., Xu C., et al. Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism. Nature 2016, 531:651-655.